Enhancing Titers of Therapeutic Lentiviral Vectors using PKC Agonists
The 3 Rs Of Replication-Competent Lentivirus (RCL) Formation Risk: Real, Rare, or Artificial?
Optimising the Production of the 4th Generation Lentiviral Vector (LV) TetraVecta™ System: Towards Plug-and-Play LV Manufacturing
The Impact of Individual Helper Genes on AAV Productivity
Evaluation of Salt-Tolerant Endonucleases for Lentiviral Vector Purification
Enhancing Upstream Processes for High-Yield, High-Quality AAV Vector Production Using a Novel In-House Cell Line
Diving Deeper: Using a SYBR Gold Capsid Ejection Assay as an Orthogonal Method of Measuring Potency and VP1 Deamidation in AAV9 Drug Product Samples
Accelerate Time to Clinic: A Platform and Analytics Approach
The TetraVecta™ System: A New Tool Kit Enhancing Lentiviral Vector Production and Performance for the Next Generation of Gene Therapies
Engineering an AAV Viral Vector Production Cell Line SV40 T Antigen Locus Removal in HEK293T via Mad7 Genome Editing
Advanced Nuclease Applications in Lentiviral Vector Bioprocessing for Superior Downstream Recovery and Vector Product Quality
TetraVecta™ Packaging Cell Lines for LV-CAR Production
